Exchange: NASDAQ·Updated 01:00 AM EDT
GOVX logo

GOVX Geovax Labs Inc

$0.2171
$0.0312
(16.78%)
Overnight
Prev Close $0.1859
Reported EarningsNov 13
Mkt Cap$1.88M
Vol146,468.00

About GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
34

Bearish Sentiment

How do you feel about GOVX?

DUherka
$GOVX so this stock is supposed to finally take off now that there is a pandemic in Russia?
3
Lyn30
$GOVX Sometime I feel like they all connected with each other. Anyway infectious disease stocks should run huge imo. Only 10M float and they need to dilute as well as plague cases in Russia. I connected the dots. Analyst pt $10 with buy rating 🦊🦊🦊🦊🦊🦊🦊🚀🚀🚀🚀
2
Italiabro
$GOVX Labs $GOVX's Market cap: is $2.17 MILLION. An incredibly small valuation for a clinical-stage biotech with vaccine and cancer-treatment programs. IP: Over 135 granted or pending patent applications across 23 patent families, covering oncology, infectious diseases and biodefense. RSI on chart at 21: Deeply oversold territory often attract bounce traders. Oct. 6: GOVX highlighted next-generation MVA vaccine and manufacturing advances at the World Vaccine Congress Europe. Sept. 29: Highlighted likely sustained Clade Ib mpox transmission in the U.S. Sept. 21: Reported preclinical evidence of durable, single-dose protection against highly pathogenic Clade I mpox. Sept. 14: Partnered with CEPI's centralized laboratory network to support the GEO-MVA Phase 3 program. Upside? GEO-MVA's development toward Phase 3 and GeoVax's broader vaccine and oncology pipeline offer potential catalysts when clinical and commercial progress is announced.
1
Jghamz94
$GOVX NASDAQ delisting determination scheduled for tomorrow. Let’s hope for some good news here.
1
Traderjoe053
$GOVX they are monitoring the situation and will soon work towards thw cure. This can fly
1
focafoca99
$GOVX concluded its special meeting with stockholders approving a reverse stock split and a warrant-exercise issuance.
Ueberschlaefer
$GOVX this means the shareholders will vote for the RS. ... you get a cumulative reverse split factor of 1-for-375,000,000,000 (375 billion). To put that into perspective: It takes 375 billion shares from 2006 to equal 1 single share of GOVX (worth ~$0.24). Back in late 2006/early 2007, the unadjusted stock traded on the Over-The-Counter Bulletin Board (OTCBB) between $0.50 and $1.00 per share. Adjusted for all the reverse splits, a single share in 2006 would have a historical chart price of roughly $187 billion to $375 billion.
UnlimitedWealth
⚠️ Have you observed ticker RETO last month going almost 7000% then dropping all the way back? ⚠️ Chinese tickers are getting out of control and destroy all the american short sellers!! I have taken a position in ticker HCAI as I personally see a lot of similarities to ticker RETO. HCAI is going to split on friday into a 350k float and I look forward to sell for a massive profit. Put ticker HCAI on watch. China is getting active again 🎰 🚀🚀 $GOVX )
Italiabro
$GOVX before this latest news, $GOVX reported preclinical data for MVA-X --- a single dose produced durable protection in animal models, including against Clade I mpox. If validated in the clinic, transitioning from a two-dose regimen toward single-dose vaccination deployment during future virus outbreaks has the potential to fundamentally change the response by public health organizations.
GuruChartist
$GOVX If there is more bad news on this vaccine front, GOVX will probably be getting calls from the Feds and/or Big Pharma Basically, more reports of U.S. Clade Ib transmission could strengthen the long-term mpox vaccine market. GOVX's GEO-MVA’s Phase 3 is pending and is an obvious news catalyst coming. JMO

Advertisement|Remove ads.